Renal Function Dependent Association of AGTR1 Polymorphism (A1166C) and Electrocardiographic Left-Ventricular Hypertrophy

American Journal of Hypertension

Volumn 20, Issue 10, 2007, Pages 1097-1103

  Smilde, Tom D J ^a   Zuurman, Mike W ^a   Hillege, Hans L ^a   van Veldhuisen, Dirk J ^a   van Gilst, Wiek H ^a   van der Steege, Gerrit ^a   Voors, Adriaan A ^a   Kors, Jan A ^b   de Jong, Paul E ^a   Navis, Gerjan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Left ventricular hypertrophy; polymorphism; PREVEND; renal function; renin angiotensin system

Indexed keywords

ADENINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; CYTOSINE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGTR1 GENE; ALLELE; ARTICLE; CALCULATION; CARDIOVASCULAR RISK; CORNELL VOLTAGE DURATION PRODUCT; CREATININE CLEARANCE; ELECTROCARDIOGRAPHY; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HARDY WEINBERG DISTRIBUTION LAW; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MEASUREMENT; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

ADULT; AGED; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HOMOZYGOTE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; LOGISTIC MODELS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTOR, ANGIOTENSIN, TYPE 1; REGRESSION ANALYSIS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 34548831966     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2007.04.023     Document Type: Article

References (32)

1. Martinez M.A., Sancho T., Armada E., Rubio J.M., Anton J.L., Torre A., Palau J., Seguido P., Gallo J., Saenz I., Polo E., Torres R., Oliver J., and Puig J.G. Prevalence of left ventricular hypertrophy in patients with mild hypertension in primary care: impact of echocardiography on cardiovascular risk stratification. Am J Hypertens 16 (2003) 556-563
2. Leoncini G., Viazzi F., Parodi D., Vettoretti S., Ratto E., Ravera M., Tomolillo C., Del Sette M., Bezante G.P., Deferrari G., and Pontremoli R. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension 42 (2003) 14-18
3. Buikema H., Pinto Y.M., Rooks G., Grandjean J.G., Schunkert H., and van Gilst W.H. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 17 (1996) 787-794
4. van Geel P.P., Pinto Y.M., Voors A.A., Buikema H., Oosterga M., Crijns H.J., and van Gilst W.H. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 35 (2000) 717-721
5. Ohishi M., Rakugi H., and Ogihara T. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 331 (1994) 1097-1098
6. Kuznetsova T., Staessen J.A., Thijs L., Kunath C., Olszanecka A., Ryabikov A., Tikhonoff V., Stolarz K., Bianchi G., Casiglia E., Fagard R., Brand-Herrmann S.M., Kawecka-Jaszcz K., Malyutina S., Nikitin Y., and Brand E. Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation 110 (2004) 2644-2650
7. Kuznetsova T., Staessen J.A., Wang J.G., Gasowski J., Nikitin Y., Ryabikov A., and Fagard R. Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis. J Hum Hypertens 14 (2000) 447-454
8. Schunkert H. Controversial association of left ventricular hypertrophy and the ACE I/D polymorphism-is the mist clearing up?. Nephrol Dial Transplant 13 (1998) 1109-1112
9. Smilde T.D., Asselbergs F.W., Hillege H.L., Voors A.A., Kors J.A., Gansevoort R.T., van Gilst W.H., de Jong P.E., and van Veldhuisen D.J. Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy. Am J Hypertens 18 (2005) 342-347
10. Brewster U.C., and Perazella M.A. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 116 (2004) 263-272
11. Sadoshima J., Xu Y., Slayter H.S., and Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75 (1993) 977-984
12. Ecder T., McFann K.K., Raynolds M.V., and Schrier R.W. No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. Am J Nephrol 23 (2003) 466-470
13. Pinto-Sietsma S.J., Janssen W.M., Hillege H.L., Navis G., de Zeeuw D., and de Jong P.E. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 11 (2000) 1882-1888
14. Zhu X., Yan D., Cooper R.S., Luke A., Ikeda M.A., Chang Y.P., Weder A., and Chakravarti A. Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the Family Blood Pressure Program. Genome Res 13 (2003) 173-181
15. Dahlof B., Devereux R., de Faire U., Fyhrquist F., Hedner T., Ibsen H., Julius S., Kjeldsen S., Kristianson K., Lederballe-Pedersen O., Lindholm L.H., Nieminen M.S., Omvik P., Oparil S., and Wedel H. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension Study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens 10 (1997) 705-713
16. Andersson B., and Sylven C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol 28 (1996) 162-167
17. Estacio R.O., Jeffers B.W., Havranek E.P., Krick D., Raynolds M., and Schrier R.W. Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus. Am J Hypertens 12 (1999) 637-642
18. Spiering W., Kroon A.A., Fuss-Lejeune M.M., Daemen M.J., and de Leeuw P.W. Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension 36 (2000) 411-416
19. Rubattu S., Di A.E., Stanzione R., Zanda B., Evangelista A., Pirisi A., De P.P., Cota L., Brunetti E., and Volpe M. Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant. J Hypertens 22 (2004) 2129-2134
20. Chapman C.M., Palmer L.J., McQuillan B.M., Hung J., Burley J., Hunt C., Thompson P.L., and Beilby J.P. Polymorphisms in the angiotensinogen gene are associated with carotid intimal-medial thickening in females from a community-based population. Atherosclerosis 159 (2001) 209-217
21. Brugada R., Kelsey W., Lechin M., Zhao G., Yu Q.T., Zoghbi W., Quinones M., Elstein E., Omran A., Rakowski H., Wigle D., Liew C.C., Sole M., Roberts R., and Marian A.J. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Invest Med 45 (1997) 542-551
22. Wang A.Y., Chan J.C., Wang M., Poon E., Lui S.F., Li P.K., and Sanderson J. Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients. Kidney Int 63 (2003) 1899-1907
23. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89 (2002) 3A-9A
24. van der Kleij F.G., de Jong P.E., Henning R.H., de Zeeuw D., and Navis G. Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake. J Am Soc Nephrol 13 (2002) 1025-1033
25. Luik P.T., Hoogenberg K., Kerstens M.N., Beusekamp B.J., de Jong P.E., Dullaart R.P., and Navis G.J. The influence of the ACE (I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric type 1 diabetes mellitus. Diabetologia 46 (2003) 1131-1139
26. Schunkert H., Hense H.W., Holmer S.R., Stender M., Perz S., Keil U., Lorell B.H., and Riegger G.A. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330 (1994) 1634-1638
27. Yildiz A., Akkaya V., Hatemi A.C., Cine N., Tukek T., Gorcin B., Demirel S., Turk S., and Sever M.S. No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients. Nephron 84 (2000) 130-135
28. Osono E., Kurihara S., Hayama N., Sakurai Y., Ohwada K., Onoda N., Takeuchi M., Tomizawa T., Komaba Y., Hashimoto K., Matsunobu S., Yoneshima H., and Iino Y. Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease. Am J Kidney Dis 32 (1998) 725-730
29. Volzke H., Engel J., Kleine V., Schwahn C., Dahm J.B., Eckel L., and Rettig R. Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. Chest 122 (2002) 31-36
30. Inoue I., Nakajima T., Williams C.S., Quackenbush J., Puryear R., Powers M., Cheng T., Ludwig E.H., Sharma A.M., Hata A., Jeunemaitre X., and Lalouel J.M. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99 (1997) 1786-1797
31. Brand-Herrmann S.M., Kopke K., Reichenberger F., Schmidt-Petersen K., Reineke T., Paul M., Zidek W., and Brand E. Angiotensinogen promoter haplotypes are associated with blood pressure in untreated hypertensives. J Hypertens 22 (2004) 1289-1297
32. Rodriguez-Perez J.C., Rodriguez-Esparragon F.J., Hernandez-Perera O., Fiuza-Perez M.D., Anabitarte-Prieto A., and Losada-Cabrera A. Effects of the angiotensinogen gene M235T and A(-6)G variants on blood pressure and other vascular risk factors in a Spanish population. J Hum Hypertens 14 (2000) 789-793